Entity Common Stock, Shares Outstanding of Edesa Biotech, Inc. from 01 Nov 2014 to 12 Dec 2025

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Edesa Biotech, Inc. quarterly Entity Common Stock, Shares Outstanding in shares history and change rate from 01 Nov 2014 to 12 Dec 2025.
  • Edesa Biotech, Inc. Entity Common Stock, Shares Outstanding for the quarter ending 12 Dec 2025 was 8,333,823, a 140% increase year-over-year.
Source SEC data
View on sec.gov
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)

Edesa Biotech, Inc. Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 8,333,823 +4,866,165 +140% 12 Dec 2025 10-K 12 Dec 2025 2025 FY
Q2 2025 7,037,648 +3,790,259 +117% 08 Aug 2025 10-Q 08 Aug 2025 2025 Q3
Q1 2025 7,022,678 +3,806,710 +118% 14 May 2025 10-Q 14 May 2025 2025 Q2
Q4 2024 3,467,658 +302,936 +9.6% 11 Dec 2024 10-K/A 20 Dec 2024 2024 FY
Q2 2024 3,247,389 -17,846,265 -85% 09 Aug 2024 10-Q 09 Aug 2024 2024 Q3
Q1 2024 3,215,968 -17,371,749 -84% 10 May 2024 10-Q 10 May 2024 2024 Q2
Q4 2023 3,164,722 -16,188,629 -84% 13 Dec 2023 10-K 15 Dec 2023 2023 FY
Q2 2023 21,093,654 +5,631,367 +36% 09 Aug 2023 10-Q 09 Aug 2023 2023 Q3
Q1 2023 20,587,717 +5,125,430 +33% 10 May 2023 10-Q 11 May 2023 2023 Q2
Q4 2022 19,353,351 +5,834,552 +43% 14 Dec 2022 10-K/A 27 Mar 2023 2022 FY
Q2 2022 15,462,287 +2,206,728 +17% 10 Aug 2022 10-Q 12 Aug 2022 2022 Q3
Q1 2022 15,462,287 +2,206,728 +17% 12 May 2022 10-Q 13 May 2022 2022 Q2
Q4 2021 13,518,799 +2,995,712 +28% 27 Dec 2021 10-K 28 Dec 2021 2021 FY
Q2 2021 13,255,559 +3,841,281 +41% 12 Aug 2021 10-Q 13 Aug 2021 2021 Q3
Q1 2021 13,255,559 +4,396,400 +50% 13 May 2021 10-Q 14 May 2021 2021 Q2
Q4 2020 10,523,087 +3,018,619 +40% 02 Dec 2020 10-K 07 Dec 2020 2020 FY
Q2 2020 9,414,278 +1,909,810 +25% 10 Aug 2020 10-Q 12 Aug 2020 2020 Q3
Q1 2020 8,859,159 +3,528,444 +66% 13 May 2020 10-Q 15 May 2020 2020 Q2
Q4 2019 7,504,468 +2,173,753 +41% 12 Dec 2019 10-KT 12 Dec 2019 2019 FY
Q2 2019 7,504,468 +2,173,753 +41% 14 Aug 2019 10-Q 14 Aug 2019 2019 Q2
Q1 2019 5,330,715 +3,827,845 +255% 06 May 2019 10-Q 08 May 2019 2019 Q2
Q4 2018 5,330,715 -5,189,381 -49% 28 Nov 2018 10-K 30 Nov 2018 2018 FY
Q2 2018 5,330,715 -5,189,381 -49% 08 Aug 2018 10-Q 08 Aug 2018 2018 Q3
Q1 2018 1,502,870 -8,633,388 -85% 07 May 2018 10-Q 07 May 2018 2018 Q2
Q4 2017 10,520,096 +383,838 +3.8% 30 Nov 2017 10-K 01 Dec 2017 2017 FY
Q2 2017 10,520,096 +383,838 +3.8% 09 Aug 2017 10-Q 09 Aug 2017 2017 Q3
Q1 2017 10,136,258 +1,687,500 +20% 09 May 2017 10-Q 09 May 2017 2017 Q2
Q4 2016 10,136,258 +1,711,500 +20% 09 Dec 2016 10-K 14 Dec 2016 2016 FY
Q2 2016 10,136,258 -69,410,392 -87% 05 Aug 2016 10-Q 09 Aug 2016 2016 Q3
Q1 2016 8,448,758 -71,097,892 -89% 05 May 2016 10-Q 09 May 2016 2016 Q2
Q4 2015 8,424,758 -71,121,892 -89% 01 Dec 2015 10-K 14 Dec 2015 2015 FY
Q2 2015 79,546,650 01 Aug 2015 10-Q 10 Aug 2015 2015 Q3
Q1 2015 79,546,650 01 May 2015 10-Q 11 May 2015 2015 Q2
Q4 2014 79,546,650 01 Feb 2015 10-Q 09 Feb 2015 2015 Q1
Q3 2014 79,121,650 01 Nov 2014 10-K 21 Nov 2014 2014 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.